For research purposes only

Cat. No BA89222480

Availability - 10 mg in stock
- larger amount can be synthesized in 8 weeks

Description of biological activity

Sodium channel blocker. In an electrophysiological assay measuring sodium channel antagonism the compound showed a Ki of 90 nM.

Keywords: Neuronal damage

TECHNICAL INFORMATION

3-(2-piperidinylethyl)-2-(3-(3-trifluoromethylphenoxy)phenyl) thiazolidin-4-one sodium channel blocker

IUPAC Name: 3-(2-piperidinylethyl)-2-(3-(3-trifluoromethylphenoxy)phenyl) thiazolidin-4-one

CAS Number: 491864-61-0

Purity: > 96% chemical purity (LCMS)

REFERENCES

1. Comb. Chem. High Throughput Screen. 2003, 6(5), 481-488

Latest added compounds

5-(4-Hydroxy-4-methyl-isoxazolidine-2-carbonyl)-1-isopropyl-3-methyl-6-(3-methyl-5-trifluoromethyl-1H-pyrazol-4-ylmethyl)-1H-thieno[2,3-d]pyrimidine-2,4-dione

Selective inhibitor of MCT1 with a binding affinity of 1.6 nM, is 6 fold selective over MCT2 and does not inhibit MCT4 at 10 μM. Both lactate transport and cell growth are potently inhibited.

Anti-cancer

Inhibitors

 
5-(4-chlorophenyl)-N-{[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl}pyridine-3-carboxamide

selective inhibitor of Nav1.8 sodium channel (IC50 = 3 nM); for TRPV1, P2X2/3, Cav2.2 calcium channels, KCNQ2/3 potassium channels IC50 >10 µM

Analgesic

Inhibitors

 
1-[4-chloro-3-(trifluoromethyl)benzenesulfonyl]-4-[4-(5-methyl-1H-pyrazol-1-yl)benzoyl]piperazine

inhibitor of ubiquitin ligase Smad ubiquitination regulatory factor-1 (Smuf1)

Bone disorders

Inhibitors